Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-000070-28Phase 2Completed
Phase 2, open-label trial of daclatasvir, simeprevir and ribavirin in hepatitis C virus infection (2 arms), sponsored by Bristol Myers Squibb. Primary endpoint: SVR12. Started Jun 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-000070-28.